Atox Bio's Series E Round

Atox Bio raised a round of funding on July 24, 2014.

Atox Bio is a clinical stage biotechnology company that develops therapeutics for diseases mediated by a deregulated inflammatory response. Atox Bio focuses on novel modulators of the immune response …

Articles about Atox Bio's Series E Round: